Spots Global Cancer Trial Database for zollinger ellison syndrome
Every month we try and update this database with for zollinger ellison syndrome cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer | NCT00001228 | Islet Cell Aden... Zollinger Ellis... | Interferon | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | NCT02831179 | Functional Panc... Malignant Somat... Merkel Cell Car... Metastatic Adre... Metastatic Carc... Multiple Endocr... Multiple Endocr... Multiple Endocr... Neuroendocrine ... Non-Functional ... Pancreatic Gluc... Pancreatic Insu... Recurrent Adren... Recurrent Adren... Recurrent Merke... Somatostatin-Pr... Stage III Adren... Stage III Thyro... Stage IIIA Merk... Stage IIIB Merk... Stage IV Adrena... Stage IV Merkel... Stage IVA Thyro... Stage IVB Thyro... Stage IVC Thyro... Thymic Carcinoi... VIP-Producing N... Well Differenti... Zollinger Ellis... | Capecitabine Temozolomide Veliparib Pharmacological... Laboratory Biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer | NCT00001228 | Islet Cell Aden... Zollinger Ellis... | Interferon | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid | NCT00001191 | Gastrinoma Zollinger Ellis... | Pantoprazole Omeprazole | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Treatment of Zollinger-Ellison Syndrome | NCT00001241 | Zollinger Ellis... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome | NCT00001254 | Zollinger Ellis... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Evaluating Patients With Abnormal Levels of Gastric Acid | NCT00001240 | Achlorhydria Gastrinoma Zollinger Ellis... | - | National Institutes of Health Clinical Center (CC) | ||
| Evaluating Patients With Abnormal Levels of Gastric Acid | NCT00001240 | Achlorhydria Gastrinoma Zollinger Ellis... | - | National Institutes of Health Clinical Center (CC) | ||
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor | NCT02831179 | Functional Panc... Malignant Somat... Merkel Cell Car... Metastatic Adre... Metastatic Carc... Multiple Endocr... Multiple Endocr... Multiple Endocr... Neuroendocrine ... Non-Functional ... Pancreatic Gluc... Pancreatic Insu... Recurrent Adren... Recurrent Adren... Recurrent Merke... Somatostatin-Pr... Stage III Adren... Stage III Thyro... Stage IIIA Merk... Stage IIIB Merk... Stage IV Adrena... Stage IV Merkel... Stage IVA Thyro... Stage IVB Thyro... Stage IVC Thyro... Thymic Carcinoi... VIP-Producing N... Well Differenti... Zollinger Ellis... | Capecitabine Temozolomide Veliparib Pharmacological... Laboratory Biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas | NCT00001165 | Islet Cell Aden... Neoplasm Metast... Zollinger Ellis... | combined chemot... | - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
